Clinical Trial Update: Glargine Versus NPH in Patients With Chronic Kidney Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing glargine and NPH insulins in patients with type 2 diabetes and chronic kidney disease has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Glargine (insulin glargine)
• NPH (insulin NPH)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Type 2 Diabetes Mellitus, Chronic Kidney Disease | Phase 4 | Status: COMPLETED | Results posted: 2017-11-07